Skip to content
Studies have shown that active fund managers routinely underperform the S&P500 index*
Home
Articles
WALL STREET X
Forecasts
Portfolios
Wall Street X
Articles
Forecasts
Portfolios
Search
Results for
{phrase}
(
{results_count}
of
{results_count_total}
)
Displaying
{results_count}
results of
{results_count_total}
Citius Pharmaceuticals, Inc. (NASDAQ: CTXR)
CTXR Stock Predictions and Ratings
WSX Rating:
STRONG BUY
WSX Forecast (1yr):
76.40%
Analyst Rating:
STRONG BUY
Analyst Forecast (1yr):
330.80%
CTXR Stock Analysis
CTXR
PE Ratio:
CTXR
PEG Ratio:
CTXR
Forward EPS Growth (12 month):
68.10%
CTXR
PS Ratio:
1.2
CTXR
PSG Ratio:
CTXR
Forward Revenue Growth (12 month):
83.60%
CTXR Articles
No data was found